The problem
Starting a biotech company means building a lab, and that is brutal. Equipment, facilities, and specialist staff cost a fortune before a single experiment runs, which locks out brilliant early-stage researchers and saddles those who push ahead with heavy overhead and expensive kit sitting idle.
What we did
NucleaLink is the lab without the overhead. It is a pay-as-you-go platform that connects biotech startups and university researchers to premium lab equipment, expert R&D services, and spare capacity at partner labs, all booked and managed through one digital platform. It leans into green chemistry and electrosynthesis, using electricity in place of harsh chemicals, with capabilities spanning high-throughput synthesis, chemical validation, and RNA drug development.
The outcome
A scalable, sustainable, and collaborative way to develop drugs, letting biotech teams run real science without owning a single lab.